These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8261427)

  • 1. Heterogeneity of subcellular localization of p53 protein in human glioblastomas.
    Ali IU; Schweitzer JB; Ikejiri B; Saxena A; Robertson JT; Oldfield EH
    Cancer Res; 1994 Jan; 54(1):1-5. PubMed ID: 8261427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
    Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An uncertain role for p53 gene alterations in human prostate cancers.
    Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB
    Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of accumulated p53 in ovarian cancer cells.
    Runnebaum IB; Kieback DG; Mobus VJ; Tong XW; Kreienberg R
    Gynecol Oncol; 1996 May; 61(2):266-71. PubMed ID: 8626145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
    McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
    J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation is a common genetic event in ovarian carcinoma.
    Milner BJ; Allan LA; Eccles DM; Kitchener HC; Leonard RC; Kelly KF; Parkin DE; Haites NE
    Cancer Res; 1993 May; 53(9):2128-32. PubMed ID: 8481915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 status has no prognostic significance in glioblastomas treated with radiotherapy.
    Baxendine-Jones J; Campbell I; Ellison D
    Clin Neuropathol; 1997; 16(6):332-6. PubMed ID: 9401801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 abnormalities in different subtypes of human sarcomas.
    Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes VA; Nesland JM; Myklebost O; Høie J; Bruland OS; Børresen AL
    Cancer Res; 1993 Feb; 53(3):468-71. PubMed ID: 8425179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.